AnyLearn Backgroung
Gadolinium-based Contrast Agents (GBCAs) are used in MRI to enhance the visibility of Internal structures, but they carry a risk of Nephrogenic Systemic Fibrosis in patients with Impaired Kidney Function. Recent developments focus on reducing Gadolinium Retention in the body to improve Patient Safety.
History Empty State Icon

Your Lessons

Your lessons will appear here when you're logged in.

All content generated by artificial intelligence. Do not rely on as advice of any kind. Accuracy not guaranteed.

Privacy policy | Terms of Use

Copyright © 2024 AnyLearn.ai All rights reserved

Feedback?